Please note: The information displayed on this page might be outdated.
MagForce AG: MagForce Nanotechnologies AG is the global leader in the field of nanotechnology cancer treatment. This revolutionary technology aims to establish a entirely new form of cancer treatment within the near future, using magnetic particles to treat tumors with very minimal side effects, thus enhancing patient quality of life. The technology and its related equipment are currently in the final phases of clinical trials. Until these have been successfully concluded, the products can only be used in conjunction with clinical trials. The products can only be sold and used in normal clinical practice once they have received regulatory approval from the responsible authorities.
Based in...
Max-Planck-Strasse 3
Berlin, 12489

Company Participants at Oktoberfest 2019 Wall Street "On Tap"

  • Hoda Tawfik, CSO

Top 10 Holders of MagForce AG

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
M&G Investment Management Ltd. 2.89 800,120 0.00 Funds 4/30/20
Skagen AS (Investment Management) 2.42 668,405 0.00 Funds 8/31/20
Baring Asset Management Ltd. 1.24 343,110 0.00 Funds 2/29/20
UBS Asset Management (Deutschland) GmbH 0.95 262,906 0.00 Funds 12/31/19
Ruffer LLP 0.41 112,032 0.00 Funds 4/30/20
KIRIX Vermögensverwaltung AG 0.14 40,000 0.00 Funds 6/30/20
Deka Investment GmbH 0.09 25,000 0.00 Funds 3/31/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.